로딩 중…
지수 로딩 중…
휴온스글로벌
084110· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩25,300-4.53%
2026-06-19
Price Chart
휴온스글로벌-46.17%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 320.29B KRW |
| Revenue | 845.30B KRW |
| Net Income | 86.21B KRW |
| Total Assets | 1.56T KRW |
| Net Assets | 1.10T KRW |
| Employees | 121 |
| Value | |
| P/E | 3.72x |
| P/B | 0.29x |
| PEG | 0.09x |
| P/S | 0.38x |
| EV/EBITDA | 5.55x |
| FCF Yield | 9.52% |
| Profitability | |
| ROE | 7.87% |
| ROA | 5.52% |
| Op. Margin | 8.77% |
| Revenue Growth | -1.08% |
| Earnings Growth | 39.30% |
| Financial Health | |
| Debt Ratio | 142.53% |
| Total Debt | 289.56B KRW |
| FCF | 30.49B KRW |
| Cash | 197.90B KRW |
| Current Ratio | 1.80x |
| Net Debt/EBITDA | 1.24x |
| Dividend | |
| Div. Yield | 3.32% |
| Div. Growth | 67.62% |
| Performance | |
| 1Y Return | -46.17% |
| 1M Return | -22.15% |
| From 52W High | -67.01% |
| 1Y MDD | -66.67% |
| Trading | |
| Volume | 53,536 shares |
| Foreign Own. | 8.25% |
| Per Share | |
| EPS | 1,878 KRW |
| BPS | 45,112 KRW |
Company Info
CEO Song Soo-young, Yoon Sung-Tae (Independent representation)
Employees 121
Founded 1987
HQ 경기도 성남시, KR
Website www.huonsglobal.com
Established as Gwangmyeong Pharmaceutical Industries in 1965, the company transitioned into a holding company in 2016. In 2021, it physically spun off its bio business, now operating as a pure holding company. As a healthcare group with 13 affiliates, including Huons and Humedix, it boasts a diverse business portfolio spanning pharmaceutical manufacturing, fillers, arthritis treatments, and medical devices. The company generates revenue from trademark usage, management consulting, dividends, and rental income, providing management guidance through subsidiary stake acquisition and ownership. Huons Global was established in 1987 and is headquartered in Seongnam-si, Gyeonggi-do.